Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts
High Business Quality and Resilient Moat Drive Veeva Systems’ (VEEV) Long-Term Investment Conviction
Veeva Systems (NYSE:VEEV): A Quality Stock With Durable Growth and a Premium Valuation
Baird Maintains Outperform on Veeva Systems, Raises Price Target to $350
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts
Barclays Maintains Overweight on Veeva Systems, Raises Price Target to $360
Veeva Systems' Research and Development Growth Tracking to Plan, Oppenheimer Says
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Veeva to Host Virtual Investor Day on November 5, 2026
Is Veeva Systems (VEEV) Quietly Redefining Clinical Tech Moats With IQVIA Deal And Basics Uptake?
Veeva Systems (VEEV) Becomes Default Clinical Software Across A Major Research Partner
Veeva Stock Breaks Out As Big Money Grabs Exposure To The AI Software Play
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Veeva Systems (VEEV) Stock Trades Up, Here Is Why
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
Vertical Software Stocks Q2 Results: Benchmarking Veeva Systems (NYSE:VEEV)
Veeva (VEEV) Stock May Be 11% Below Fair Value After Biotech Adoption News
Software Leader Veeva Systems Positioned To Hit Buy Points After Nearly Doubling
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.